Open original FDA record ↗Recall record
- FDA identifier
- Z-0958-2013
- Company in FDA record
- Beckman Coulter Inc.
- FDA classification date
- Mar 15, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Beckman Coulter is including additional information and instructions in the Creatinine (OSR6x78) IFU and Setting Sheet, relating to calibration stability and quality control frequency to assure product performance.
Source facts
- Action
- Beckman Coulter sent an Urgent Product Correction letter to all affected customers. The letter identified the affected product, problem and actions to be taken. The letter informed the customers that Beckman Coulter is including additional information and instructions in the Creatinine (OSR6x78) IFU and Setting Sheet, relating to calibration stability and quality control frequency to assure product performance. Customers are instructed to complete and return the enclosed response form. Customers with questions about the notification letter are instructed to contact the call center (hotline) at (800) 854-3633 in the US and Canada.
- Initiated
- 2012-12-28
- Root cause
- Labeling design
- Terminated
- 2013-10-17
- Distribution
- Worldwide Distribution - USA Nationwide and the countries of: Canada, Brazil, Colombia, Mexico, Puerto Rico, Venezuela, Guam, Honduras, Peru, Ecuador, Costa Rica.
- Recall number
- Z-0958-2013
- Recall status
- Terminated
- CDRH record ID
- 115469
- FDA classified
- 2013-03-15
- Recall event number
- 64162